Am J Transplant, Volume 18, Suppl 3 Archives - Page 15 of 211 - ATC Abstracts

2018 American Transplant Congress
Long-Term Effects of Ketoconazole in Rapid Tacrolimus Metabolizers Post-Renal Transplantation
J. Ching,¹ S. Anders,¹ M. Janusek,¹ L. Hutchinson,¹ A. Freeman,¹ U. Patel,¹ A. Mohammed,⁴ H. Bohorquez.^2,3
¹Department of Pharmacy, Ochsner Clinical Foundation, New Orleans, LA; ²Multi-Organ Transplant Institute, Ochsner Clinical Foundation, New Orleans, LA; ³The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA; ⁴Academic Center, Ochsner Clinical Foundation, New Orleans, LA.
Introduction: Genetic polymorphisms in cytochrome P-450 enzymes can cause variations in tacrolimus (tac) metabolism. Ketoconazole (keto), a potent CYP450 and P-glycoprotein inhibitor, can be used…
2018 American Transplant Congress
Clinical Significance of Tacrolimus Trough Level at the Early Period after Kidney Transplantation
W. Park,^1,2 S. Yeo,¹ S. Kang,^1,2 H. Park,¹ K. Jin,^1,2 S. Park,^1,2 S. Han.^1,2
¹Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea; ²Keimyung University Kidney Institute, Daegu, Republic of Korea.
Background:The stable immunosuppressant level at the early period after kidney transplantation (KT) is one of the most important factors to decide the prognosis of KT.…
2018 American Transplant Congress
Mycophenolate Monotherapy is Safe and Effective in HLA-Matched Kidney Transplant Recipients
A. Hennes, K. Holdener, W. Burlingham, B. Astor, A. Djamali.
UW Health, Madison, WI.
Purpose: The ideal minimizing strategy for maintenance immunosuppression in HLA-matched kidney transplant recipients (KTR) is unknown. We hypothesized that mycophenolate (MPA) monotherapy is a safe…
2018 American Transplant Congress
Liposomal Bupivacaine: Friend or Foe in Kidney Donation?
Y. Yang, A. Jantz, B. Summers, A. Patel, L. Malinzak, N. Sulejmani.
Henry Ford Hospital, Detroit, MI.
Background: Pain following nephrectomy and concerns for opioid dependence are disincentives to living kidney donors (LKD). Efficacy of liposomal bupivacaine (LB) in post-operative care of…
2018 American Transplant Congress
Experience and Safety of Hand-Assisted Laparoscopic Nephrectomy for Living Kidney Donors at Mexico´s General Hospital "Dr. Eduardo Liceaga"
P. Prieto-Olivares, L. Garcia-Covarrubias, A. Bahena-Portillo, A. Cicero-Lebrija, V. Visag-Castillo, H. Hinojosa-Heredia, D. Fernandez-Angel, Y. Carrión, A. Rosas, E. Pedraza, I. Castro, A. García-Covarrubias, H. Diliz-Perez.
Organ Transplantation, Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico City, Mexico.
Background: Hand-assisted laparoscopic nephrectomy (HALN) is the procedure of choice for living kidney donors. Our center is a public hospital that serves low-income patients from…
2018 American Transplant Congress
Temporary Contraindication of Obese Recipients in Kidney Transplantation: A New Morphometric Tool for Decision Support
U. Pinar,¹ Y. Renard,² D. Bedretdinova,³ C. Lebacle,¹ B. Parier,¹ Y. Hamoudi,¹ J. Irani,¹ T. Bessede.¹
¹Department of Urology, Hopitaux Universitaires Paris-Sud, Le Kremlin-Bicetre, France; ²Department of Digestive Surgery, University Hospital of Reims, Reims, France; ³U1018, INSERM, Villejuif, France.
IntroductionBased on body mass index (BMI) and/or clinical examination, morbid obesity can be a temporary contraindication (TCI) of kidney transplantation. However, BMI alone does not…
2018 American Transplant Congress
Kidney Transplantation Alone in End-Stage Renal Disease Patients with Hepatitis B Liver Cirrhosis
M. Jang,¹ M. Lee,² S. Kim.¹
¹Division of Nephrology, Department of Internal Medicine, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Republic of Korea; ²Division of Nephrology, Department of Internal Medicine, Choengju St. Mary's General Hospital, Choengjusi, Republic of Korea.
BackgroundKidney transplantation (KT) alone in end-stage renal disease (ESRD) patients with hepatitis B virus-induced liver cirrhosis (LC) remains controversial. This study compared outcomes of KT…
2018 American Transplant Congress
Treatment of BK Viremia: Single-Center Experience
A. Karim, A. Hines, K. Wang, S. Saleh, B. Suleiman, W. Hassan, A. Maibam, M. Yaseen, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid, A. El-Husseini.
Nephrology, University of Kentucky, Lexington, KY.
INTRODUCTION:BK viremia (BKV) and BK virus nephropathy (BKVN) is recognized as an emerging problem in renal transplant recipients. Only reduction of immunosuppressants had shown efficacy…
2018 American Transplant Congress
Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT)
G. Malat, D. Reich, G. Xiao, M. Harhay, K. Ranganna, D. Lee, S. Guy, S. Munoz.
Drexel University, Philadelphia.
Background: Deceased donor orthotopic liver transplantation (OLT) can result in significant delayed function, manifesting as protracted hyperbilirubinemia, depending on the intensity of the ischemia/reperfusion injury…
2018 American Transplant Congress
Comprehensive Validation of Different Clinical Prediction Models on Short- and Long-Term Outcome Following Orthotopic Liver Transplantation
J. Boecker,¹ Z. Czigany,¹ J. Bednarsch,¹ I. Amygdalos,¹ F. Meister,¹ D. Morales Santana,¹ W. Schoening,¹ T. Ulmer,¹ M. Krebbers,¹ G. Koek,¹ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
¹Department of Surgery and Transplantation, University Hospital RWTH, Aachen, Germany; ²Department of Internal Medicine III, University Hospital RWTH, Aachen, Germany.
Background: Organ shortage remains a major problem in orthotopic liver transplantation (OLT). An optimal utilization of the donor pool with better prediction of outcome is…